Rockefeller Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$926 Buy
+64
New +$1.1K ﹤0.01% 4660
2026
Q2
– Sell
-5
Closed -$87 – 4876
2026
Q1
$87 Sell
5
-12
-71% -$238 ﹤0.01% 4641
2025
Q4
$334 Sell
17
-5
-23% -$104 ﹤0.01% 4562
2025
Q3
$606 Buy
+22
New +$677 ﹤0.01% 4252
2023
Q1
– Sell
-4
Closed – – 3799
2022
Q4
$0 Hold
4
– – ﹤0.01% 4229
2022
Q3
$0 Sell
4
-29
-88% -$1.92K ﹤0.01% 4394
2022
Q2
$2K Buy
33
+29
+725% +$2.16K ﹤0.01% 3843
2022
Q1
$0 Buy
+4
New – ﹤0.01% 4074
2021
Q4
– Sell
-27
Closed -$2K – 3995
2021
Q3
$2K Buy
+27
New +$2.6K ﹤0.01% 3487
2021
Q1
– Sell
-3,660
Closed -$282K – 3397
2020
Q4
$282K Hold
3,660
– – ﹤0.01% 1083
2020
Q3
$269K Hold
3,660
– – ﹤0.01% 956
2020
Q2
$269K Hold
3,660
– – ﹤0.01% 874
2020
Q1
$211K Hold
3,660
– – ﹤0.01% 803
2019
Q4
$287K Hold
3,660
– – ﹤0.01% 691
2019
Q3
$250K Hold
3,660
– – ﹤0.01% 583
2019
Q2
$291K Hold
3,660
– – ﹤0.01% 522
2019
Q1
$307K Hold
3,660
– – ﹤0.01% 544
2018
Q4
$431K Buy
+3,660
New +$423K 0.01% 339

Other funds holding USNA

Rockefeller Capital Management's USNA Position: Q3 2026 in Review

Rockefeller Capital Management opened a new position in Usana Health Sciences (USNA) in Q3 2026: 64 shares worth $926. The stake represents ﹤0.01% of the portfolio and ranks #4660 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in USNA as recently as Q1 2026.

Rockefeller Capital Management first reported a position in USNA in Q4 2018 and has held it in 18 quarters since. The position peaked at $431K in Q4 2018. 128 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Rockefeller Capital Management held 64 shares of Usana Health Sciences worth $926 as of Q3 2026.
  • Usana Health Sciences was a new Rockefeller Capital Management position in Q3 2026.
  • Usana Health Sciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4660 holding.
  • Rockefeller Capital Management first reported a position in Usana Health Sciences in Q4 2018 and has held it in 18 quarters since.
  • Rockefeller Capital Management's Usana Health Sciences position peaked at $431K in Q4 2018.
  • 128 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.